Loading...
Please wait, while we are loading the content...
Similar Documents
Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells
| Content Provider | Semantic Scholar |
|---|---|
| Author | Novella, Susana Laguna-Fernández, Andrés Lázaro-Franco, Macarena Sobrino, Agua Hermenegildo, Carlos |
| Copyright Year | 2013 |
| Abstract | Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthase. ADMA accumulation, mainly due to a decreased dimethylarginine dimethylaminohydrolase (DDAH) activity, has been related to the development of cardiovascular diseases. We investigate whether estradiol prevents the changes induced by oxidized low density lipoprotein (oxLDL) on the DDAH/ADMA/NO pathway in human umbilical artery endothelial cells (HUAEC). HUAEC were exposed to estradiol, native LDL (nLDL), oxLDL and their combinations for 24 h. In some experiments, cells were also exposed to the unspecific estrogen receptor (ER) antagonist ICI 182780, the specific ERα antagonist MPP or specific agonists for ERα, ERβ and GPER. ADMA concentration was measured by HPLC and concentration of NO by amperometry. Protein expression and DDAH activity were measured by immunoblotting and an enzymatic method, respectively. oxLDL, but not nLDL, increased ADMA concentration with a concomitant decrease on DDAH activity. oxLDL reduced eNOS protein and NO production. Estradiol alone had no effects on DDAH/ADMA/NO pathway, but increased the attenuated endothelial NO production induced by oxLDL by reduction in ADMA and preventing loss of eNOS protein levels. ICI 182780 and MPP completely abolished these effects of estradiol on oxLDL-exposed cells. ERα agonist, but not ERβ and GPER agonists, mirrored estradiol effects on NO production. In conclusion, estradiol restores (1) DDAH activity, and therefore ADMA levels, and (2) NO production impaired by oxLDL in HUAEC acting through ERα. |
| Starting Page | 11 |
| Ending Page | 16 |
| Page Count | 6 |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.mce.2012.08.020 |
| PubMed reference number | 22982060 |
| Journal | Medline |
| Volume Number | 365 |
| Alternate Webpage(s) | http://roderic.uv.es/bitstream/handle/10550/32815/081274.pdf;jsessionid=2DDA18503BCF2190E6A42F991E79FAF2?sequence=1 |
| Alternate Webpage(s) | http://redheracles.net/media/upload/research/pdf/229820601391778775.pdf |
| Alternate Webpage(s) | https://api.elsevier.com/content/article/pii/S0303720712004157 |
| Alternate Webpage(s) | https://www.sciencedirect.com/science/article/pii/S0303720712004157?dgcid=api_sd_search-api-endpoint |
| Alternate Webpage(s) | https://doi.org/10.1016/j.mce.2012.08.020 |
| Journal | Molecular and Cellular Endocrinology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
